Explanatory note
(This note is not part of the Regulations)
These Regulations make amendments to Regulations relating to community pharmaceutical services.
Part 2 of these Regulations makes amendments to the National Health Service (Local Pharmaceutical Services etc.) Regulations 2006 (“the 2006 Regulations”). Regulation 3 adds a definition of “notice” to make it clear that notices have to be in writing. Consequential amendments are made to regulations 8 and 15(5)(b) and paragraph 22(10) of Schedule 2 to the 2006 Regulations.
Regulation 5 also amends regulation 14(1)(a) of the 2006 Regulations to make it clear that an LPS scheme (a type of arrangement for providing community pharmaceutical services) must include dispensing services as set out in paragraph 3 of Schedule 2 to the 2006 Regulations.
Part 3 of these Regulations makes miscellaneous amendments to the National Health Service (Pharmaceutical Services) Regulations 2005. Together with miscellaneous drafting improvements and corrections, the amendments include amendments of—
the requirements for notification of the decision and the corresponding rights of appeal in cases to which regulation 6(1) or 7(1) of the Regulations relate (applications for minor relocations within a Primary Care Trust or between neighbouring Primary Care Trusts) (regulations 19 and 21);
the appeal rights in connection with determinations in respect of controlled localities (regulation 27);
the procedure after the grant of an application so that an applicant can be included in a pharmaceutical list before 30 days have expired, where there is good cause (regulation 28);
the provisions relating to payments to suspended chemists (regulation 36).
A full regulatory impact assessment has not been produced for this instrument as no additional impact on the private or voluntary sectors is foreseen.